Search:   [Advanced]

Search Results

Search for "Bisoprolol" returned 26 results

previous12next

Showing 1-20 out of 26

DrugBank ID	Name	Formula	Weight
DB00612	Bisoprolol	C18H31NO4	325.4430
	... hydrochlorothiazide) Bisoprolol Bisoprolol Pathway SMP00300 Bisoprolol is a competitive, beta(1)-selective (cardioselective) adrenergic antagonist. Bisoprolol is used to treat hypertension ...
DB00236	Pipobroman	C10H16Br2N2O2	356.0540
	... Atenolol Antagonism Betaxolol Antagonism Bevantolol Antagonism Bisoprolol Antagonism Carteolol Antagonism Carvedilol Antagonism Esmolol Antagonism Labetalol Antagonism Metoprolol Antagonism ...
DB00983	Formoterol	C19H24N2O4	344.4049
	... Atenolol Antagonism Betaxolol Antagonism Bevantolol Antagonism Bisoprolol Antagonism Carteolol Antagonism Carvedilol Antagonism Esmolol Antagonism Labetalol Antagonism Metoprolol Antagonism ...
DB01288	Fenoterol	C17H21NO4	303.3529
	... Atenolol Antagonism Betaxolol Antagonism Bevantolol Antagonism Bisoprolol Antagonism Carteolol Antagonism Carvedilol Antagonism Clomipramine The tricyclic increases the sympathomimetic effect ...
DB00816	Orciprenaline	C11H17NO3	211.2576
	... Atenolol Antagonism Betaxolol Antagonism Bevantolol Antagonism Bisoprolol Antagonism Carteolol Antagonism Carvedilol Antagonism Clomipramine The tricyclic increases the sympathomimetic effect ...
DB00871	Terbutaline	C12H19NO3	225.2842
	... Atenolol Antagonism Betaxolol Antagonism Bevantolol Antagonism Bisoprolol Antagonism Carteolol Antagonism Carvedilol Antagonism Clomipramine The tricyclic increases the sympathomimetic effect ...
DB00247	Methysergide	C21H27N3O2	353.4580
	... with risk of gangrene Bevantolol Ischemia with risk of gangrene Bisoprolol Ischemia with risk of gangrene Carteolol Ischemia with risk of gangrene Carvedilol Ischemia with risk of gangrene ...
DB00457	Prazosin	C19H21N5O4	383.4011
	... Bevantolol Risk of hypotension at the beginning of therapy Bisoprolol Risk of hypotension at the beginning of therapy Carteolol Risk of hypotension at the beginning of therapy Carvedilol Risk ...
DB00554	Piroxicam	C15H13N3O4S	331.3460
	... Bevantolol Risk of inhibition of renal prostaglandins Bisoprolol Risk of inhibition of renal prostaglandins Carteolol Risk of inhibition of renal prostaglandins Carvedilol Risk of inhibition ...
DB00575	Clonidine	C9H9Cl2N3	230.0940
	... Bevantolol Increased hypertension when clonidine stopped Bisoprolol Increased hypertension when clonidine stopped Carteolol Increased hypertension when clonidine stopped Carvedilol Increased ...
DB01050	Ibuprofen	C13H18O2	206.2808
	... Bevantolol Risk of inhibition of renal prostaglandins Bisoprolol Risk of inhibition of renal prostaglandins Bumetanide The NSAID decreases the diuretic and antihypertensive effect of the loop ...
DB00280	Disopyramide	C21H29N3O	339.4745
	... Bevantolol The beta-blocker increases toxicity of disopyramide Bisoprolol The beta-blocker increases toxicity of disopyramide Carteolol The beta-blocker increases toxicity of disopyramide ...
DB00328	Indomethacin	C19H16ClNO4	357.7880
	... Bevantolol Risk of inhibition of renal prostaglandins Bisoprolol Risk of inhibition of renal prostaglandins Bumetanide The NSAID decreases the diuretic and antihypertensive effects of the loop ...
DB00414	Acetohexamide	C15H20N2O4S	324.3950
	... The beta-blocker decreases the symptoms of hypoglycemia Bisoprolol The beta-blocker decreases the symptoms of hypoglycemia Carteolol The beta-blocker decreases the symptoms of hypoglycemia ...
DB00672	Chlorpropamide	C10H13ClN2O3S	276.7400
	... Bismuth The salicylate increases the effect of sulfonylurea Bisoprolol The beta-blocker decreases the symptoms of hypoglycemia Carteolol The beta-blocker decreases the symptoms of hypoglycemia ...
DB00912	Repaglinide	C27H36N2O4	452.5857
	... The beta-blocker decreases the symptoms of hypoglycemia Bisoprolol The beta-blocker decreases the symptoms of hypoglycemia Carteolol The beta-blocker decreases the symptoms of hypoglycemia ...
DB01120	Gliclazide	C15H21N3O3S	323.4110
	... The salicylate increases the effect of sulfonylurea Bisoprolol The beta-blocker decreases the symptoms of hypoglycemia Carteolol The beta-blocker decreases the symptoms of hypoglycemia ...
DB01162	Terazosin	C19H25N5O4	387.4329
	Initiate concomitant therapy cautiously. Bisoprolol Increased risk of hypotension. Initiate concomitant therapy cautiously. Carteolol Increased risk of hypotension. Initiate concomitant therapy ...
DB01308	Insulin-glargine	C267H408N72O77S6	6050.9226
	... Subsalicylate The salicylate increases the effect of insulin Bisoprolol The beta-blocker decreases the symptoms of hypoglycemia Carteolol The beta-blocker decreases the symptoms of ...
DB01016	Glibenclamide	C23H28ClN3O5S	494.0040
	... The salicylate increases the effect of sulfonylurea Bisoprolol The beta-blocker decreases the symptoms of hypoglycemia Bosentan Increased risk of hepatic toxicity Carteolol The beta-blocker ...

Showing 1-20 out of 26

previous12next

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.